| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
11,776 |
9,969 |
$1.63M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,971 |
4,127 |
$1.32M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
13,679 |
11,925 |
$1.27M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,327 |
1,957 |
$831K |
| 80053 |
Comprehensive metabolic panel |
29,874 |
22,647 |
$552K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
6,664 |
5,976 |
$508K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,035 |
6,304 |
$473K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
28,207 |
22,206 |
$337K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,213 |
1,078 |
$324K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,987 |
3,509 |
$274K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
989 |
841 |
$263K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,332 |
2,028 |
$259K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
3,560 |
3,304 |
$254K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
8,054 |
7,035 |
$231K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,370 |
2,422 |
$227K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
8,029 |
6,588 |
$202K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,902 |
1,916 |
$195K |
| 84443 |
Thyroid stimulating hormone (TSH) |
9,398 |
8,422 |
$193K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,305 |
4,943 |
$187K |
| 71046 |
Radiologic examination, chest; 2 views |
3,018 |
2,642 |
$180K |
| 71045 |
Radiologic examination, chest; single view |
6,270 |
5,259 |
$179K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,712 |
4,626 |
$178K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,206 |
936 |
$169K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,062 |
1,014 |
$165K |
| 81001 |
|
12,775 |
10,665 |
$136K |
| 80061 |
Lipid panel |
6,613 |
6,154 |
$129K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,706 |
2,310 |
$127K |
| 87081 |
|
10,250 |
9,322 |
$120K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
11,138 |
9,325 |
$116K |
| 84484 |
|
5,495 |
4,139 |
$114K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,167 |
1,613 |
$114K |
| 83690 |
|
5,058 |
4,079 |
$108K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,660 |
3,053 |
$104K |
| 85027 |
|
9,010 |
5,966 |
$101K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,812 |
4,206 |
$99K |
| 83735 |
|
6,912 |
3,708 |
$98K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,163 |
2,883 |
$92K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,974 |
4,628 |
$91K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,981 |
1,193 |
$85K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,797 |
4,827 |
$82K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,955 |
3,653 |
$81K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,782 |
4,491 |
$79K |
| 73630 |
|
1,209 |
1,014 |
$73K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
400 |
346 |
$72K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,824 |
4,464 |
$71K |
| 36415 |
Collection of venous blood by venipuncture |
18,353 |
13,606 |
$70K |
| 82607 |
|
4,138 |
3,781 |
$68K |
| 85610 |
|
3,978 |
3,089 |
$65K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,024 |
1,711 |
$63K |
| 82550 |
|
2,738 |
2,241 |
$57K |
| 87186 |
|
2,750 |
2,300 |
$55K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,094 |
1,783 |
$54K |
| 81025 |
|
1,903 |
1,511 |
$54K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
524 |
464 |
$50K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
406 |
372 |
$50K |
| 96376 |
|
1,597 |
955 |
$50K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,087 |
1,775 |
$49K |
| 87040 |
|
1,400 |
878 |
$47K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,856 |
2,039 |
$44K |
| G0378 |
Hospital observation service, per hour |
1,083 |
432 |
$43K |
| 85007 |
|
4,384 |
2,353 |
$41K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
619 |
316 |
$39K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,951 |
1,850 |
$38K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
811 |
667 |
$37K |
| 97014 |
|
744 |
223 |
$36K |
| 87077 |
|
2,159 |
1,864 |
$34K |
| 85730 |
|
1,064 |
880 |
$33K |
| 87070 |
|
1,247 |
1,055 |
$31K |
| 73610 |
|
641 |
553 |
$31K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
967 |
785 |
$31K |
| 76830 |
Ultrasound, transvaginal |
499 |
440 |
$31K |
| 97161 |
|
684 |
605 |
$29K |
| 83880 |
|
1,258 |
1,092 |
$28K |
| 84439 |
|
1,827 |
1,636 |
$28K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,231 |
1,143 |
$28K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
293 |
260 |
$28K |
| 72110 |
|
285 |
255 |
$27K |
| 84466 |
|
2,097 |
1,868 |
$27K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
189 |
159 |
$27K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
482 |
410 |
$26K |
| 83605 |
|
2,822 |
2,205 |
$26K |
| 82728 |
|
1,974 |
1,738 |
$26K |
| 86850 |
|
1,936 |
1,561 |
$26K |
| 84703 |
|
1,439 |
1,181 |
$25K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
370 |
336 |
$25K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
254 |
168 |
$25K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
287 |
248 |
$24K |
| 83540 |
|
2,292 |
2,039 |
$24K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,591 |
1,395 |
$24K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,636 |
1,264 |
$22K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,244 |
1,018 |
$22K |
| 82553 |
|
384 |
306 |
$22K |
| 82746 |
|
1,684 |
1,507 |
$21K |
| 74018 |
|
420 |
350 |
$20K |
| 86900 |
|
1,929 |
1,527 |
$19K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
589 |
539 |
$19K |
| 73030 |
|
574 |
481 |
$18K |
| 73562 |
|
452 |
366 |
$18K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,863 |
1,302 |
$17K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
15 |
13 |
$17K |
| 86803 |
|
1,242 |
1,085 |
$15K |
| 86140 |
|
1,258 |
1,065 |
$14K |
| 59025 |
Fetal non-stress test |
253 |
139 |
$14K |
| 84702 |
|
531 |
363 |
$14K |
| 36592 |
|
124 |
110 |
$14K |
| 84550 |
|
850 |
685 |
$12K |
| 87147 |
|
631 |
526 |
$12K |
| 83615 |
|
1,357 |
1,054 |
$11K |
| 87480 |
|
910 |
801 |
$11K |
| A9576 |
Injection, gadoteridol, (prohance multipack), per ml |
143 |
131 |
$11K |
| 73130 |
|
215 |
180 |
$11K |
| 82962 |
|
2,633 |
1,325 |
$10K |
| 87660 |
|
908 |
800 |
$10K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
198 |
144 |
$10K |
| 87510 |
|
908 |
800 |
$10K |
| 73110 |
|
167 |
140 |
$10K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,234 |
1,139 |
$10K |
| 85651 |
|
654 |
572 |
$10K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
458 |
449 |
$9K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
655 |
409 |
$9K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
19 |
12 |
$9K |
| 93041 |
|
141 |
124 |
$9K |
| 96367 |
|
347 |
176 |
$8K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
187 |
53 |
$8K |
| 82570 |
|
925 |
744 |
$8K |
| 82803 |
|
597 |
441 |
$8K |
| 81002 |
|
564 |
482 |
$8K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
599 |
438 |
$8K |
| 87088 |
|
149 |
127 |
$8K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
942 |
746 |
$8K |
| 87340 |
|
804 |
699 |
$7K |
| 82248 |
|
1,988 |
1,632 |
$7K |
| 76536 |
|
38 |
37 |
$7K |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
689 |
597 |
$7K |
| 85379 |
|
785 |
672 |
$7K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
367 |
209 |
$6K |
| 82565 |
|
227 |
156 |
$6K |
| 86762 |
|
224 |
194 |
$6K |
| 93971 |
|
52 |
43 |
$6K |
| 72050 |
|
19 |
15 |
$6K |
| 80050 |
General health panel |
156 |
147 |
$6K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
809 |
604 |
$6K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
435 |
380 |
$5K |
| 94760 |
|
554 |
298 |
$5K |
| 73564 |
|
170 |
141 |
$5K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
98 |
92 |
$5K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
87 |
77 |
$5K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
73 |
62 |
$5K |
| 84153 |
|
213 |
194 |
$5K |
| 82043 |
|
572 |
521 |
$5K |
| 0064U |
|
87 |
69 |
$5K |
| 86780 |
|
500 |
429 |
$4K |
| 84156 |
|
210 |
128 |
$4K |
| 90686 |
|
352 |
333 |
$4K |
| 73590 |
|
32 |
24 |
$4K |
| 20610 |
|
64 |
50 |
$4K |
| 86618 |
|
273 |
180 |
$3K |
| 87205 |
|
409 |
341 |
$3K |
| 88142 |
|
153 |
133 |
$3K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
67 |
66 |
$3K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
179 |
170 |
$3K |
| 86901 |
|
1,415 |
1,132 |
$3K |
| 84100 |
|
251 |
148 |
$3K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
144 |
137 |
$3K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
73 |
64 |
$2K |
| 86787 |
|
193 |
170 |
$2K |
| 90715 |
|
173 |
160 |
$2K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
68 |
68 |
$2K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
94 |
36 |
$2K |
| 51700 |
|
76 |
26 |
$2K |
| 86038 |
|
103 |
98 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
822 |
584 |
$2K |
| 73502 |
|
112 |
96 |
$2K |
| J2060 |
Injection, lorazepam, 2 mg |
51 |
36 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
1,503 |
1,166 |
$1K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
18 |
13 |
$1K |
| 80179 |
|
158 |
138 |
$1K |
| 85046 |
|
231 |
201 |
$1K |
| 87430 |
|
206 |
200 |
$1K |
| 20611 |
|
12 |
12 |
$1K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
46 |
45 |
$1K |
| 86592 |
|
32 |
30 |
$1K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
12 |
12 |
$1K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
85 |
84 |
$996.87 |
| 80143 |
|
140 |
123 |
$951.60 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
340 |
264 |
$851.03 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
19 |
17 |
$816.97 |
| 86706 |
|
107 |
91 |
$789.44 |
| 84630 |
|
184 |
171 |
$779.24 |
| 83970 |
|
27 |
26 |
$770.31 |
| 85652 |
|
488 |
427 |
$769.74 |
| 90656 |
|
109 |
102 |
$754.43 |
| 84520 |
|
87 |
64 |
$754.40 |
| 93880 |
|
12 |
12 |
$735.23 |
| 82378 |
|
127 |
90 |
$717.64 |
| 86704 |
|
59 |
54 |
$632.69 |
| 80076 |
|
63 |
54 |
$613.11 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
535 |
271 |
$593.96 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
226 |
110 |
$530.00 |
| 84145 |
|
49 |
38 |
$525.81 |
| 71250 |
|
14 |
14 |
$494.18 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
300 |
211 |
$427.51 |
| 82947 |
|
127 |
111 |
$413.68 |
| 82950 |
|
73 |
69 |
$353.50 |
| 94727 |
|
26 |
25 |
$350.84 |
| 94060 |
|
27 |
26 |
$340.71 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
17 |
16 |
$340.04 |
| 93356 |
|
189 |
175 |
$262.89 |
| 88304 |
|
29 |
13 |
$257.48 |
| 88342 |
|
12 |
12 |
$243.72 |
| 94729 |
|
14 |
13 |
$222.31 |
| G0008 |
Administration of influenza virus vaccine |
85 |
76 |
$212.07 |
| 87807 |
|
15 |
15 |
$187.14 |
| 82105 |
|
15 |
14 |
$180.37 |
| 93017 |
|
13 |
13 |
$175.48 |
| 0065U |
|
326 |
292 |
$146.65 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
121 |
90 |
$140.96 |
| Q3014 |
Telehealth originating site facility fee |
23 |
22 |
$131.87 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
145 |
111 |
$124.99 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
97 |
95 |
$95.35 |
| 84460 |
|
35 |
29 |
$90.74 |
| 84450 |
|
34 |
28 |
$85.87 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
26 |
12 |
$80.46 |
| 86431 |
|
16 |
16 |
$78.44 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
314 |
249 |
$58.12 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
121 |
81 |
$53.98 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
17 |
14 |
$46.00 |
| 96127 |
|
13 |
12 |
$37.70 |
| 90694 |
|
54 |
47 |
$37.53 |
| 51798 |
|
19 |
14 |
$22.40 |
| 76376 |
|
264 |
237 |
$20.65 |
| 90653 |
|
19 |
17 |
$18.87 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
16 |
16 |
$10.62 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
49 |
39 |
$9.13 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
20 |
16 |
$8.49 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
14 |
12 |
$8.26 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
14 |
12 |
$1.50 |
| J3490 |
Unclassified drugs |
1,868 |
876 |
$1.35 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
17 |
12 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
25 |
14 |
$0.00 |
| G1010 |
Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program |
19 |
12 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
15 |
13 |
$0.00 |